Back

Arrhythmogenic atrial substrate in suspected heart failure with preserved ejection fraction: implications for development of future atrial fibrillation

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome Heart Failure in Atrial Fibrillation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Bjoern Mueller-Edenborn

University Heart Centre Freiburg-Bad Krozingen, Bad Krozingen (Germany)

9 More presentations in this session

Presentation thumbnail
Role of nocturnal hypoxemic burden for disease-orientated assessment of sleep apnea severity in ambulatory patients with atrial fibrillation.
Professor D. Linz (Maastricht, NL)
Abstract
Presentation thumbnail
Subclinical atrial fibrillation and clinical outcome in patients with pacemaker
Associate Professor Y. Park (Seoul, KR)
Abstract
Presentation thumbnail
Guideline-directed therapy at discharge is important in patients with heart failure and atrial fibrillation
Professor M. Ahn (Wonju, KR)
Abstract Slides
Presentation thumbnail
Atrial fibrillation in arrhythmogenic right ventricular cardiomyopathy and its association with ventricular arrhythmias.
Doctor M. Baturova (Lund, SE)
Abstract Slides
Presentation thumbnail
Predictors of de novo atrial arrhythmia after isolated surgical aortic valve replacement in severe degenerative aortic stenosis
Assistant Professor Y. Hwang (Suwon, KR)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources